Abstract
Several key reports from the American Heart Association meeting, held in Orlando (FL, USA) in November 2011, are presented related to anti-thrombotic therapy in acute coronary syndrome and the use of dronedarone in permanent atrial fibrillation is discussed in this brief (and selective) overview of this meeting. A summary of the ATLAS-TIMI-51, TRACER and PALLAS trials is provided.
| Original language | English |
|---|---|
| Pages (from-to) | 305-7 |
| Number of pages | 3 |
| Journal | Expert review of cardiovascular therapy |
| Volume | 10 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 1 Mar 2012 |